Cytos News
Most Popular Cytos Story
Cytos touts one-size-fits-all vax, hints at $541M deal
Swiss researchers claim to have found a 'one size fits all' allergy shot for hay fever, asthma and eczema, adding that it could be available within four to five years, the Telegraph reports. The... Read more...
Latest Headlines
- August 21, 2008
- March 13, 2008
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
